Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer
- PMID: 17124162
- PMCID: PMC1856455
Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer
Comment on
-
Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.Gut. 2006 Jun;55(6):759-61. doi: 10.1136/gut.2005.085274. Gut. 2006. PMID: 16698750 Free PMC article.
-
Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.Gut. 2006 Nov;55(11):1671-2. Gut. 2006. PMID: 17047121 Free PMC article. No abstract available.
References
-
- Popat S, Hubner R, Houlston R S. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 200523609–618. - PubMed
-
- Elsaleh H, Powell B, McCaul K.et al P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 200171343–1349. - PubMed
-
- Liang J T, Huang K C, Lai H S.et al High‐frequency microsatellite instability predicts better chemosensitivity to a high‐dose 5‐fluorouracil plus leukovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection. Int J Cancer 2002101519–525. - PubMed
-
- Brueckl W M, Moesch C, Brabletz T.et al Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first‐line chemotherapy. Anticancer Res 2003231773–1777. - PubMed
-
- Hemminki A, Mecklin J P, Jarvinen H.et al Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000119921–928. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical